Yüklüyor......
Characterization and Prognostic Significance of Cutaneous Adverse Events to Anti-Programmed Cell Death-1 Therapy
BACKGROUND: Anti-programmed cell death-1 (PD-1) immunotherapy using antibodies such as nivolumab or pembrolizumab has shown promise for treating various types of cancer. In this study, we reviewed the frequency and spectrum of cutaneous adverse events (AEs) caused by PD-1 antibodies and their possib...
Kaydedildi:
| Yayımlandı: | J Korean Med Sci |
|---|---|
| Asıl Yazarlar: | , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
The Korean Academy of Medical Sciences
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6609422/ https://ncbi.nlm.nih.gov/pubmed/31269545 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3346/jkms.2019.34.e186 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|